James Michael Mitchell

James Michael Mitchell

Auto-generated profile, based on publicly available information

James Michael Mitchell

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GTGiuliano Testa
Giuliano Testa
GMG. J. McKenna
G. J. McKenna
RJR. T. Gunby Jr
R. T. Gunby Jr
TAT. Anthony
T. Anthony
EKE. C. Koon
E. C. Koon
LJL. Johannesson
L. Johannesson
Uterus transplantation has proven to be a successful treatment for women with absolute uterine infertility, caused either by the absence of a uterus or the presence of a nonfunctioning uterus. We report the first birth of a healthy child following uterus transplantation in the United States, from a recipient of a uterus allograft procured from an altruistic living donor. Two major modifications from the previously reported live births characterized this uterus transplant. First, the transplanted uterus relied upon and sustained the pregnancy while having only the utero‐ovarian vein as venous outflow. The implication is a significantly simplified living donor surgery that paves the way for minimally invasive laparoscopic or robot‐assisted techniques for the donor hysterectomy. Second, the time from transplantation to embryo transfer was significantly shortened from prior protocols, allowing for an overall shorter exposure to immunosuppression by the recipient and lowering the risk for potential adverse effects from these medications.

1 November 2017 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GTGiuliano Testa
Giuliano Testa
EKE. C. Koon
E. C. Koon
LJL. Johannesson
L. Johannesson
GMG. J. McKenna
G. J. McKenna
TAT. Anthony
T. Anthony
MOM. Olausson
M. Olausson
Uterus transplantation is a vascularized composite allograft transplantation. It allows women who do not have a uterus to become pregnant and deliver a baby. In this paper, we analyze the first five cases of living donor uterus transplantation performed in the United States. The first three recipients lost their uterus grafts at days 14, 12, and 6, respectively, after transplant. Vascular complications, related to both inflow and outflow problems, were identified as the primary reason for the graft losses. Two recipients, at 6 and 3 mo, respectively, after transplant, have functioning grafts with regular menstrual cycles. Ultimate success will be claimed only after a live birth. This paper is an in-depth analysis of evaluation, surgical technique, and follow-up of these five living donor uterus transplants. The lessons learned were instrumental in allowing us to evolve from failure to technical and functional success. We aim to share our conclusions and build on knowledge in the evolving field of uterus transplantation.

1 July 2015 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MFMaryjane Farr
Maryjane Farr
JMJames Mitchell
James Mitchell
MLMatthew Lippel
Matthew Lippel
TKTomoko S. Kato
Tomoko S. Kato
ZJZhezhen Jin
Zhezhen Jin
PSP. Christian Schulze
P. Christian Schulze

1 June 2015 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
HYHui-Min Yang
Hui-Min Yang
JMJames M. Mitchell
James M. Mitchell
JSJorge L. Sepulveda
Jorge L. Sepulveda
ASAntonia R. Sepulveda
Antonia R. Sepulveda
Context: Colorectal cancer is a heterogeneous disease resulting from different molecular pathways of carcinogenesis. Recent data evaluating the histologic features and molecular basis of the serrated polyp–carcinoma pathway have significantly contributed to more comprehensive classifications of and treatment recommendations for these tumors. Objective: To integrate the most recent molecular findings in the context of histologic classifications of serrated lesions and their implications in diagnostic pathology and colorectal cancer surveillance. Data Sources: Published literature focused on serrated polyps and their association with colorectal cancer. Conclusions: Three types of serrated polyps are currently recognized: hyperplastic polyps, sessile serrated adenomas/polyps, and traditional serrated adenomas. The BRAF V600E mutation is one of the most frequent molecular abnormalities identified in hyperplastic polyps and sessile serrated adenomas. In contrast, in traditional serrated adenomas, either BRAF V600E or KRAS mutations can be frequently identified. CpG methylation has emerged as a critical molecular mechanism in the sessile serrated pathway. CpG methylation of MLH1 often leads to reduced or lost expression in dysplastic foci and carcinomas arising in sessile serrated adenomas/polyps.

30 March 2020 in Clinical Endoscopy
Verified
Journal Article
Open access
YCYongYan Cui
YongYan Cui
LKLauren G. Khanna
Lauren G. Khanna
ASAnjali Saqi
Anjali Saqi
JCJohn P. Crapanzano
John P. Crapanzano
JMJames M. Mitchell
James M. Mitchell
JPJohn M. Poneros
John M. Poneros
The management of small, incidentally discovered nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has been a matter of debate. Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) is a tool used to identify and risk-stratify PNETs. This study investigates the concordance rate of Ki67 grading between EUS-FNA and surgical pathology specimens in NFPNETs and whether certain NF-PNET characteristics are associated with disease recurrence and disease-related death. We retrospectively reviewed the clinical history, imaging, endoscopic findings, and pathology records of 37 cases of NFPNETs that underwent pre-operative EUS-FNA and surgical resection at a single academic medical center. There was 73% concordance between Ki67 obtained from EUS-FNA cytology and surgical pathology specimens; concordance was the highest for low- and high-grade NF-PNETs. High-grade Ki67 NF-PNETs based on cytology (p=0.028) and histology (p=0.028) were associated with disease recurrence and disease-related death. Additionally, tumors with high-grade mitotic rate (p=0.005), tumor size >22.5 mm (p=0.104), and lymphovascular invasion (p=0.103) were more likely to have poor prognosis. NF-PNETs with high-grade Ki67 on EUS-FNA have poor prognosis despite surgical resection. NF-PNETs with intermediate-grade Ki67 on EUS-FNA should be strongly considered for surgical resection. NF-PNETs with low-grade Ki67 on EUSFNA can be monitored without surgical intervention, up to tumor size 20 mm.

1 November 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Open access
JMJames Michael Mitchell
James Michael Mitchell
RDRakheja Dinesh
Rakheja Dinesh
PGPurva Gopal
Purva Gopal